PRIMIX BIO VENTURES: what changed
PRIMIX BIO VENTURES
Largest movements
- Cash -€354,327
down €354,327 (-79.1%), from €447,791 to €93,463
mainly Current investments (-€327,778) and Receivables within one year (-€150,219)
- Current investments +€327,778
up €327,778 (+101%), from €326,065 to €653,843
- Receivables within one year +€150,219
up €150,219 (+69.6%), from €215,697 to €365,916
of which Other amounts receivable: +€81,854
- Deferred charges and accrued income -€24,439
down €24,439 (-76.8%), from €31,827 to €7,388
- Reserves +€106,274
up €106,274 (+9.7%), from €1.1m to €1.2m
of which Distributable reserves: +€85,224
- Other debts -€25,000
no longer reported in 2025 (was €25,000)
- Tax, wage and social debts +€24,930
up €24,930 (+105%), from €23,761 to €48,691
of which Taxes: +€27,511
- Gross operating margin -€78,091
down €78,091 (-31.2%), from €250,357 to €172,266
- Taxes -€25,694
down €25,694 (-32.2%), from €79,724 to €54,030
- Depreciation +€21,934
up €21,934 (+185%), from €11,868 to €33,802
- Financial income -€15,242
down €15,242 (-39.0%), from €39,052 to €23,810
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,177,811 | €1,280,381 | +€102,570 | +8.7% |
| Fixed assets | 21/28 | €156,432 | €159,770 | +€3,339 | +2.1% |
| Tangible fixed assets | 22/27 | €156,432 | €159,770 | +€3,339 | +2.1% |
| Plant, machinery and equipment | 23 | €3,307 | €2,945 | -€362 | -11.0% |
| Furniture and vehicles | 24 | €153,125 | €148,975 | -€4,149 | -2.7% |
| Other tangible fixed assets | 26 | - | €7,850 | +€7,850 | |
| Current assets | 29/58 | €1,021,379 | €1,120,611 | +€99,232 | +9.7% |
| Amounts receivable within one year | 40/41 | €215,697 | €365,916 | +€150,219 | +69.6% |
| Trade receivables | 40 | €18,639 | €87,005 | +€68,366 | +367% |
| Other amounts receivable | 41 | €197,057 | €278,911 | +€81,854 | +41.5% |
| Current investments | 50/53 | €326,065 | €653,843 | +€327,778 | +101% |
| Cash at bank and in hand | 54/58 | €447,791 | €93,463 | -€354,327 | -79.1% |
| Deferred charges and accrued income | 490/1 | €31,827 | €7,388 | -€24,439 | -76.8% |
| Total equity and liabilities | 10/49 | €1,177,811 | €1,280,381 | +€102,570 | +8.7% |
| Equity | 10/15 | €1,108,634 | €1,214,908 | +€106,274 | +9.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,090,034 | €1,196,308 | +€106,274 | +9.7% |
| Tax-exempt reserves | 132 | €100,314 | €121,364 | +€21,050 | +21.0% |
| Distributable reserves | 133 | €989,720 | €1,074,944 | +€85,224 | +8.6% |
| Amounts payable | 17/49 | €69,177 | €65,473 | -€3,704 | -5.4% |
| Amounts payable within one year | 42/48 | €58,730 | €62,754 | +€4,023 | +6.9% |
| Trade debts | 44 | €9,970 | €14,063 | +€4,093 | +41.1% |
| Suppliers | 440/4 | €9,970 | €14,063 | +€4,093 | +41.1% |
| Taxes, remuneration and social security | 45 | €23,761 | €48,691 | +€24,930 | +105% |
| Taxes | 450/3 | €21,180 | €48,691 | +€27,511 | +130% |
| Remuneration and social security | 454/9 | €2,580 | - | -€2,580 | |
| Other amounts payable | 47/48 | €25,000 | - | -€25,000 | |
| Accrued charges and deferred income | 492/3 | €10,447 | €2,719 | -€7,727 | -74.0% |
| Non-recurring operating income | 76A | €2,392 | - | -€2,392 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €11,868 | €33,802 | +€21,934 | +185% |
| Other operating charges | 640/8 | €1,673 | €1,884 | +€211 | +12.6% |
| Non-recurring operating charges | 66A | €714 | - | -€714 | |
| Gross operating margin | 9900 | €250,357 | €172,266 | -€78,091 | -31.2% |
| Operating profit (loss) | 9901 | €236,101 | €136,579 | -€99,522 | -42.2% |
| Financial income | 75/76B | €39,052 | €23,810 | -€15,242 | -39.0% |
| Recurring financial income | 75 | €39,052 | €23,810 | -€15,242 | -39.0% |
| Financial charges | 65/66B | €91 | €85 | -€6 | -6.5% |
| Recurring financial charges | 65 | €91 | €85 | -€6 | -6.5% |
| Profit (loss) for the period before taxes | 9903 | €275,062 | €160,304 | -€114,758 | -41.7% |
| Income taxes | 67/77 | €79,724 | €54,030 | -€25,694 | -32.2% |
| Profit (loss) for the period | 9904 | €195,337 | €106,274 | -€89,063 | -45.6% |
| Transfer to tax-exempt reserves | 689 | €84,200 | €21,050 | -€63,150 | -75.0% |
| Profit (loss) for the period to be appropriated | 9905 | €111,137 | €85,224 | -€25,913 | -23.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.